- CEO
- Mutsumi Kimura
- Full Time Employees
- 5,720
- Sector
- Consumer non-durables
- Industry
- Beverages: alcoholic
- Address
- 20 Naginataboko-cho Kyoto KY Japan 600-8008
- IPO Date
- May 16, 1949
- Business
- Takara Holdings Inc. is a holding company primarily engaged in the manufacture and sale of alcoholic beverages, seasonings, biomedical products, and related services through its subsidiaries. Takara Shuzo produces and sells Japanese alcoholic beverages (washu) including shochu, sake, and light-alcohol refreshers; imported Chinese alcoholic beverages and whisky; seasonings such as Hon-mirin; and raw alcohol. Takara Shuzo International Group exports Japanese liquors, manufactures and sells alcoholic beverages overseas, and wholesales Japanese foodstuffs including seafood, rice, and seasonings. Takara Bio Group supplies genetic research reagents and instruments under brands such as TaKaRa, Clontech, and Cellartis; genetic testing kits; genome analysis services; iPS cell research products; CDMO services for regenerative medicine including viral vectors, gene therapy, and cell processing; and contract research for biologics development.
The company operates across domestic and international markets, with subsidiaries in Japan, the United States (Berkeley, CA; Frankfort, KY; El Monte, CA), United Kingdom, France, Spain, Portugal, Germany, Australia, China, Canada, India, and South Korea, focusing on alcoholic beverages, Japanese food wholesale, life sciences, printing, real estate leasing, logistics, and marketing services.
Founded in 1925 and headquartered in Kyoto, Japan, Takara Holdings traces its origins to a sake brewery established in 1842 and employs approximately 5,729 people on a consolidated basis.
In recent developments, Takara Shuzo International completed the acquisition of 90% membership interest in Germany's Kagerer & Co. GmbH, a Japanese food wholesaler specializing in seafood and Asian foods, in December 2024 to expand its European wholesale network under the TaKaRa Group Medium-Term Management Plan for 2025. Takara Bio USA Holdings acquired Curio Bioscience in January 2025, enhancing its spatial genomics and single-cell NGS capabilities with the Trekker platform.